Prediagnostic sex steroid hormones in relation to male breast cancer risk
File(s)jco%2E2014%2E59%2E1602.pdf (232.28 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Purpose
Although previous studies have implicated a variety of hormone-related risk factors in the etiology of male breast cancers, no previous studies have examined the effects of endogenous hormones.
Patients and Methods
Within the Male Breast Cancer Pooling Project, an international consortium comprising 21 case-control and cohort investigations, a subset of seven prospective cohort studies were able to contribute prediagnostic serum or plasma samples for hormone quantitation. Using a nested case-control design, multivariable unconditional logistic regression analyses estimated odds ratios and 95% CIs for associations between male breast cancer risk and 11 individual estrogens and androgens, as well as selected ratios of these analytes.
Results
Data from 101 cases and 217 matched controls were analyzed. After adjustment for age and date of blood draw, race, and body mass index, androgens were found to be largely unrelated to risk, but circulating estradiol levels showed a significant association. Men in the highest quartile had an odds ratio of 2.47 (95% CI, 1.10 to 5.58) compared with those in the lowest quartile (trend P = .06). Assessment of estradiol as a ratio to various individual androgens or sum of androgens showed no further enhancement of risk. These relations were not significantly modified by either age or body mass index, although estradiol was slightly more strongly related to breast cancers occurring among younger (age < 67 years) than older men.
Conclusion
Our results support the notion of an important role for estradiol in the etiology of male breast cancers, similar to female breast cancers.
Although previous studies have implicated a variety of hormone-related risk factors in the etiology of male breast cancers, no previous studies have examined the effects of endogenous hormones.
Patients and Methods
Within the Male Breast Cancer Pooling Project, an international consortium comprising 21 case-control and cohort investigations, a subset of seven prospective cohort studies were able to contribute prediagnostic serum or plasma samples for hormone quantitation. Using a nested case-control design, multivariable unconditional logistic regression analyses estimated odds ratios and 95% CIs for associations between male breast cancer risk and 11 individual estrogens and androgens, as well as selected ratios of these analytes.
Results
Data from 101 cases and 217 matched controls were analyzed. After adjustment for age and date of blood draw, race, and body mass index, androgens were found to be largely unrelated to risk, but circulating estradiol levels showed a significant association. Men in the highest quartile had an odds ratio of 2.47 (95% CI, 1.10 to 5.58) compared with those in the lowest quartile (trend P = .06). Assessment of estradiol as a ratio to various individual androgens or sum of androgens showed no further enhancement of risk. These relations were not significantly modified by either age or body mass index, although estradiol was slightly more strongly related to breast cancers occurring among younger (age < 67 years) than older men.
Conclusion
Our results support the notion of an important role for estradiol in the etiology of male breast cancers, similar to female breast cancers.
Date Issued
2015-05-11
Date Acceptance
2015-05-01
Citation
Journal of Clinical Oncology, 2015, 33 (18), pp.2041-2050
ISSN
1527-7755
Publisher
American Society of Clinical Oncology
Start Page
2041
End Page
2050
Journal / Book Title
Journal of Clinical Oncology
Volume
33
Issue
18
Copyright Statement
© 2015 by American Society of Clinical Oncology
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000361652800011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
BASE-LINE CHARACTERISTICS
BODY-MASS INDEX
POSTMENOPAUSAL WOMEN
KLINEFELTER-SYNDROME
COLLABORATIVE REANALYSIS
ESTROGEN METABOLISM
REPLACEMENT THERAPY
EPIC COHORT
MEN
PREMENOPAUSAL
Aged
Androgens
Breast Neoplasms, Male
Case-Control Studies
Cohort Studies
Estradiol
Gonadal Steroid Hormones
Hormones
Humans
International Cooperation
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Risk Factors
Oncology & Carcinogenesis
1112 Oncology And Carcinogenesis
Publication Status
Published